The market performance of Fate Therapeutics Inc has been somewhat stable. Over the past year, the company’s stock achieved a high of $8.83 on 03/07/24, with the lowest value for the same timeframe being $1.96, recorded on 11/15/24.
52-week price history of FATE Stock
A stock’s 52-week high and low prices can reveal a great deal about its present condition and potential future performance. Fate Therapeutics Inc’s current trading price is -71.18% away from its 52-week high, while its distance from the 52-week low is 29.85%. The stock’s price range during this period has fluctuated between $1.96 and $8.83. Shares of the company, which operates in the Healthcare sector, recorded a trading volume of around 8.67 million for the day, which was evidently higher than the average daily volume of 1.75 million over the last three months.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Financial Performance and Market Capitalization
Fate Therapeutics Inc (FATE) has experienced a quarterly decline of -27.49% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 289.86M and boasts a workforce of 181 employees.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 3.45, with a change in price of -0.63. Similarly, Fate Therapeutics Inc recorded 1,939,269 in trading volume during the last 100 days, posting a change of -20.19%.
FATE Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for FATE stands at 0.27. Similarly, the long-term debt-to-equity ratio is also 0.25.
FATE Stock Stochastic Average
Fate Therapeutics Inc’s raw stochastic average for the past 50 days is currently at 23.66%. This represents a fall from the raw stochastic average of the last 20 days, which was recorded at 34.42%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 28.57% and 21.07%, respectively.
FATE Stock Price Performance Analysis
Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. Year to date metric has recorded a loss of -31.95%.However, over the last six months, we can see a stronger performance of -25.80%. Over the last 30 days, the price of FATE has leaped by -11.32%. And in the last five days, it has surged by 16.74%.
